Evaluation reports
EN
RNMCD - Récepteurs nucléaires, maladies cardiovasculaires et diabète
Type: Research entity evaluation report
Evaluation campaign: 2024-2025 (group E)
- Published on: 30/01/2025
Institution(s) concerned:
Université de Lille
, CHRU - Centre hospitalier régional et universitaire de Lille
, Institut national de la santé et de la recherche médicale - INSERM
, Institut Pasteur Lille
Disciplinary research field: Life and Earth Sciences (SVE) ; SVE6 Public Health, Epidemiology, Clinical Research
Scientific field(s): 5 - Biologie, medecine et santé
ERC panel(s): LS Life Sciences ; LS3 Cellular and Developmental Biology: cell biology, cell physiology, signal transduction, organogenesis, developmental genetics, pattern formation in plants and animals ; LS4 Physiology, Pathophysiology and Endocrinology: organ physiology, pathophysiology, endocrinology, metabolism, ageing, regeneration, tumorigenesis, cardiovascular disease, metabolic syndrome
Keywords: Nuclear receptors ; Cardiovascular and metabolic disease ; Heart valve disease ; Inflammation ; Pharmacogy